Informatie:
Fout:
ID
34454
Beschrijving
Emotional and Cognitive Subthalamic Nucleus in Deep Brain Stimulation Treated Parkinson Patients; ODM derived from: https://clinicaltrials.gov/show/NCT01590056
Link
https://clinicaltrials.gov/show/NCT01590056
Trefwoorden
Versies (1)
- 17-01-19 17-01-19 -
Houder van rechten
see on clinicaltrials.gov
Geüploaded op
17 januari 2019
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Parkinson's Disease NCT01590056
Eligibility Parkinson's Disease NCT01590056
- StudyEvent: Eligibility
Similar models
Eligibility Parkinson's Disease NCT01590056
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
ID.1
Item
clinically definite pd treated / candidates for treatment with dbs (patients with advanced idiopathic pd who are deemed appropriate for dbs surgery).
boolean
ID.2
Item
patients will be included in the study irrespective of whether a diagnosis of major depression (mild to moderate but not severe mdd) is fulfilled at baseline. patients without depression will be monitored in the study for evidence of treatment emergent depression. patients with depression will be monitored for antidepressant effects of stimulation change.
boolean
ID.3
Item
age 40-75 years
boolean
ID.4
Item
male or female.
boolean
ID.5
Item
competent and willing to give written informed consent.
boolean
ID.6
Item
significant suicidal risk [hamilton depression scale item 3 (suicide) >2].
boolean
ID.7
Item
comorbidity with any psychotic disorder, bipolar disorder, post traumatic stress disorder (ptsd), eating disorder.
boolean
ID.8
Item
lifetime history of substance or alcohol dependence or of abuse in the preceding 12 months
boolean
ID.9
Item
significant cognitive decline, as measured by addenbrooke's cognitive examination (ace) and the frontal assessment battery (fab).
boolean